Skip to main content

MoneyWorks4Me

Lupin informs about disclosure of related party transactions

23 Nov 2022 Evaluate

In compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Lupin has informed that it enclosed disclosure of Related Party Transactions for the half-year ended September 30, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1305.00
Cipla 1350.00
Lupin 1959.05
Zydus Lifesciences 1167.00
View more..